# A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

> **NCT06200207** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 680 (estimated)

## Conditions studied

- Heart Failure
- Systemic Inflammation

## Interventions

- **DRUG:** Ziltivekimab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06200207
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-01-08
- **Target enrollment:** 680 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200207, "A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06200207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*